ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,819.10
0.78%
S&P ASX All Technology
3,330.90
0.60%
Brent Oil
67.075
0.00%
US Dollar vs AUD
1.56535
0.00%
Bitcoin
85,154.01
0.79%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Skye Bioscience Inc (SKYE) Share Price

Skye Bioscience Inc

Skye Bioscience Inc (SKYE)

First Trust Cloud Computing UCITS ETF Class A Accumulation
First Trust Cloud Computing UCITS ETF Class A Accumulation
1.435
-0.145
(-9.18%)
Closed 19 April 6:00AM
Delayed by 15 minutes
1.4302
-0.0048
(-0.33%)
After Hours: 9:49AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.4302
Bid
1.42
Offer
1.43
Volume
587,704
1.41 Day's Range 1.65
1.14 52 Week Range 17.6473
Market Cap
44.3M
Previous Close
1.58
Open
1.58
Last Trade
23
@
1.43
Last Trade Time
Financial Volume
US$ 888,151
VWAP
1.5112
Average Volume (3m)
691,876
Shares Outstanding
30,974,558
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
6.24M
Net Profit
-26.57M

About Skye Bioscience Inc

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. It researches and develops and plans to commercialize cannabinoid derivatives through its own directed research efforts and through several license agreements with the University of Mississippi. The compan... Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. It researches and develops and plans to commercialize cannabinoid derivatives through its own directed research efforts and through several license agreements with the University of Mississippi. The company's lead compound, SBI-100, is initially being developed to treat ocular disease. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
skyebioscience.com
Headquarters
Carson City, Nevada, USA
Founded
-
Skye Bioscience Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SKYE. The last closing price for Skye Bioscience was US$1.58. Over the last year, Skye Bioscience shares have traded in a share price range of US$ 1.14 to US$ 17.6473.

Skye Bioscience currently has 30,974,558 shares in issue. The market capitalisation of Skye Bioscience is US$48.94 million.

Ask ADVFN Intelligence (AI)

SKYE Latest News

More News

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
21 March 2025
SKYE (-9.18%)

Form 8-K - Current report
Edgar (US Regulatory)
21 March 2025
SKYE (-9.18%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
21 March 2025
SKYE (-9.18%)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Edgar (US Regulatory)
01 March 2025
SKYE (-9.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 February 2025
SKYE (-9.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 February 2025
SKYE (-9.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 February 2025
SKYE (-9.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 February 2025
SKYE (-9.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 February 2025
SKYE (-9.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 February 2025
SKYE (-9.18%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.09026.731343283581.343.7271.2457982591.6993888CS
4-0.5698-28.4923.7271.1416456141.70792399CS
12-1.1698-44.99230769232.64.251.146918761.92408222CS
26-2.8598-66.6620046624.295.961.144175862.38215615CS
52-15.5198-91.562241887916.9517.64731.143369483.84426576CS
156-12.0698-89.405925925913.517.64731.143324623.87056469CS
260-12.0698-89.405925925913.517.64731.143324623.87056469CS

SKYE - Frequently Asked Questions (FAQ)

What is the current Skye Bioscience share price?
The current share price of Skye Bioscience is US$ 1.4302
How many Skye Bioscience shares are in issue?
Skye Bioscience has 30,974,558 shares in issue
What is the market cap of Skye Bioscience?
The market capitalisation of Skye Bioscience is USD 48.94M
What is the 1 year trading range for Skye Bioscience share price?
Skye Bioscience has traded in the range of US$ 1.14 to US$ 17.6473 during the past year
What is the reporting currency for Skye Bioscience?
Skye Bioscience reports financial results in USD
What is the latest annual turnover for Skye Bioscience?
The latest annual turnover of Skye Bioscience is USD 6.24M
What is the latest annual profit for Skye Bioscience?
The latest annual profit of Skye Bioscience is USD -26.57M
What is the registered address of Skye Bioscience?
The registered address for Skye Bioscience is 701 S CARSON ST, STE 200, CARSON CITY, NEVADA, 89701
What is the Skye Bioscience website address?
The website address for Skye Bioscience is skyebioscience.com
Which industry sector does Skye Bioscience operate in?
Skye Bioscience operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MSGMMotorsport Games Inc
US$ 2.69
(140.18%)
37M
SXTCChina SXT Pharmaceuticals Inc
US$ 2.11
(113.37%)
51.73M
ADGMAdagio Medical Holdings Inc
US$ 1.68
(81.98%)
115.48M
PNBKPatriot National Bancorp Inc
US$ 3.28
(73.54%)
1.57M
RTCBaijiayun Group Ltd
US$ 0.3601
(67.49%)
187.02M
LXEHLixiang Education Holding Company Ltd
US$ 8.25
(-64.11%)
1.55M
CLIKClick Holdings Ltd
US$ 0.355
(-48.18%)
13.52M
IOTRiOThree Ltd
US$ 1.1409
(-38.33%)
3.93M
FMTOFemto Technologies Inc
US$ 0.0191
(-35.47%)
198.4M
SISIShineco Inc
US$ 0.5809
(-35.07%)
824.91k
DMNDamon Inc
US$ 0.0034
(9.68%)
409.39M
STSSSharps Technology Inc
US$ 0.03195
(20.57%)
391.8M
SUNESUNation Energy Inc
US$ 0.0176
(-10.20%)
349.4M
NVDANVIDIA Corporation
US$ 101.49
(-2.87%)
292.48M
HTZHertz Global Holdings Inc
US$ 8.205
(43.70%)
266.91M

Discussion

View Full Feed
uber darthium uber darthium 48 seconds ago
No more website. I bet holding Gerald’s bags are really heavy. I remember how many shares you proudly purchased from these coin machine fraudsters EASTERLIED, the serial diluter Billy “Utah” DelCrappo, UtterlyDumb, and our Peteygrams still laughing from his grave. His wife thanks SHMP shareholder
SHMP
BDEZ BDEZ 4 minutes ago
Power, once consolidated, is reluctant to surrender. Even stone gives way to water given enough time and pressure ~ Daniel Miller, President of Texit
236T568 236T568 4 minutes ago
Yes!
https://bsky.app/profile/kyledcheney.bsky.social/post/3ln5eof4t3223
georgejjl georgejjl 13 minutes ago
Have a very happy EASTER!!!

Good luck and GOD bless,
AVXL
Zorax Zorax 15 minutes ago
Just speculating here about the what the shitface administration is doing with el salvadore case.
I think the ghouls have done plenty of what ifs with everything they are doing plus years of planning and reading the room.
I don't think anything would surprise them, so my spec is that
ListenToTheTrees ListenToTheTrees 17 minutes ago
For the resident stock “experts” around these parts:

AS-authorized shares
OS-outstanding shares

It is important to understand the difference, especially if it’s not “your first rodeo” or claim to have “seen it all”

.

https://investor
HMBL
Brysh Brysh 28 minutes ago
CFO of ModuLink (IDVV) post on LinkedIn a couple months ago:

ModuLink Australia is proud to introduce our latest update - Australia Semi Modular Homes! 🏡✨ Combining quality craftsmanship with affordability, our semi modular homes are designed to meet your needs for a co
IDVV
Brysh Brysh 31 minutes ago
“Australia's looming election brings housing crisis into focus”

“Buying or renting a home has become unaffordable for the average Australian, driven by a perfect storm of astronomical house prices, relentless rental increases and a lack of social housing.”


https
IDVV
Swammmie1040 Swammmie1040 32 minutes ago
Looks like APSI holdings was the one that was involved in the 30 million commans added to the unrestricted and restricted a month or so ago to get the restricted shares over 10% so they could file to get rid of unsolicited quotes only barrier or 15c2-11..those 30 million were not listed on the annua
APSI
TooFrank TooFrank 32 minutes ago
And a… positive Firefly Review

Show Speed In China? | Firefly Review

https://m.youtube.com/watch?v=-jXkcArLYVY
NIO
Jimmy Joe Jimmy Joe 34 minutes ago
New SEC head Atkins will not do anything but distort what already is happening.

How do I know this~? Just look at this administration and Binance. All an effort to make Trumpy more money. Then there is Billy Long the chosen to head the IRS. Google it.

This all blowing u
AMC
Konaploinks Konaploinks 39 minutes ago
Doc. Now what we have here. Is a failure to communicate. I know SK Telcom and Intellian and I D Quantique want to communicate along with darpa and AFRL etc But they got to get their quantum minds right. Think beyond heterogenous. Get your mind right. I’m shakin it boss. I’m shakin it.
Quant
IONQ
georgejjl georgejjl 42 minutes ago
Of course if Anavex's blarcamesine is taken before bedtime without any other sigma-1 receptor competitive ligands, then blarcamesine will achieve its maximum efficacy.

Good luck and GOD bless,
AVXL
hotmeat hotmeat 45 minutes ago
This is the board for Vivos, a company on the cusp of a major Cancer treatment breakthrough......ICYMI.
RDGL
redspeed redspeed 46 minutes ago
I calculate if the sp falls below 0.001, I suspect the Series B holders will likely initiate a series of lawsuits as they may be underwater.

I would guess they are not happy that Pulsewire flopped along with IndexR

Apparently the plan B Sheild thingie...

MONI
TooFrank TooFrank 49 minutes ago
And… another not so promising Firefly review.
Chinese don’t buy small premium vehicles.

https://m.youtube.com/watch?v=_rx1ieryuBc
NIO
nowwhat2 nowwhat2 49 minutes ago
Hey that fellow came to our home a few times and maybe even jammed with us once or twice (not that I can play at all, I'd kinda just strum and hum along)......
The harp i can play tho, might's tried that.....
No wonder a few people kept saying "oooh ooh, it's John Prine !"
I re
KRISGO KRISGO 50 minutes ago
IMO, this wasn’t just a typical pump-and-dump like we’ve seen before. I believe a rumor or leak out of the UK triggered the initial spike in Stuttgart(73%), which was then followed by a 40% surge in the OTC market. Monday is shaping up to be a very interesting day—if there’s actual news, we could se
NWBO
Zorax Zorax 50 minutes ago
Why does RFK jr's head always look like a discarded crumpled beer can.
dstock07734 dstock07734 53 minutes ago
Are you trying to be funny? What makes you think that you can have discussions with the longs in a few years? Probably by mid-2025, the world will know $NWBO has the biggest breakthrough ever in medicine.

Now answer two simple questions:
Which treatment on this planet can trig
NWBO
Oddlot Oddlot 53 minutes ago
Update: SPX, GOLD, GDX
Objectives SPX 4500-4300 early 2026, with small interim bounce for 3-4 weeks, subsequent low and bounce in June-July, followed by final drop. Fundamentals may drive SPX to 3700.

GOLD objective remains 3550, but dollar weakness may continue move further.
GDX
Neverhadawinner Neverhadawinner 54 minutes ago
OPPS!

$5 Billion revenue write off caused by that China Thing! I think the 114% revenue growth figure is a little high.
NVDA
GrandAdmiralThrawn GrandAdmiralThrawn 55 minutes ago
Except the one thing, this isn’t a juggernaut AI CEO, you’re making this guy out to be bigger than Elon or even the great Steve Jobs. Stop over-inflating the worth of this guy, TN.
GCAN
pothen pothen 55 minutes ago
Penny, IMHO, I don't think your post adds any value to my inquiry. You post the same things every day, and a lot of it has not brought any value to the share price. I am tired of hearing about a supposed third dividend, tired of hearing about gold prices going up, tired of hearing about pulling ce
AABB

Your Recent History

NASDAQ
SKYE
Skye Bioscience
Delayed Upgrade Clock
ADVFN Logo
Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads